Badreddin Edris - Jan 6, 2022 Form 4 Insider Report for SpringWorks Therapeutics, Inc. (SWTX)

Role
Chief Operating Officer
Signature
/s/ Francis I. Perier, Jr. as Attorney-in Fact
Stock symbol
SWTX
Transactions as of
Jan 6, 2022
Transactions value $
$0
Form type
4
Date filed
1/10/2022, 03:27 PM
Previous filing
Jul 1, 2021
Next filing
Jan 10, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SWTX Common Stock Award +26.1K +8.66% 328K Jan 6, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SWTX Stock Option (Right to Buy) Award $0 +81.4K $0.00 81.4K Jan 6, 2022 Common Stock 81.4K $59.46 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction represents a grant of restricted stock units ("RSUs"). The RSUs shall vest as follows: thirty three percent (33%) to vest on January 6, 2023, another thirty three percent (33%) to vest on January 6, 2024 and the remaining thirty four percent (34%) to vest on January 6, 2025, such that the restricted stock awards are fully vested on January 6, 2025.
F2 This option shall vest in 48 equal monthly installments subject to continued service to the company by the Reporting Person.